According to literature reports, COVID-19-associated hypercoagulable state is characterized by elevated levels of D-dimer, fibrinogen, factor VIII (FVIII), and von Willebrand factor (vWF), together with reduced ADAMTS-13 activity (13–15). The gene discussed is VWF; the disease is COVID-19.